Ligand ID: VGH


Drugbank ID:
DB08865
(Crizotinib)



Indication:
Crizotinib is used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic-lymphoma kinase (ALK)-positive as detected by a FDA-approved test.